We Source What Heals - With the Same Rigor We Apply to Billion-Dollar IT Deals
Peptides. Exosomes. Stem cells. NAD+. RampRate's 24-year procurement intelligence engine now serves the healing economy - verified provenance, benchmarked quality, and disclosed pricing on every transaction.
Every Category - Benchmarked, Verified, and Ready to Source
We benchmark every category against closed transactions from the last 90 days - documented, auditable, and negotiated on your behalf. We're a sourcing partner, not a price list: exact figures are shared once we understand your fit, not before.
Peptides
BPC-157, TB-500, TB-4, CJC-1295, GHK-Cu, Epithalon, MOTS-c, and custom-synthesis compounds. cGMP certified. COA, HPLC, and mass spec on every lot.
Exosomes
MSC-derived, platelet-rich, and plant-based exosome carriers. IV-grade and topical. NTA particle sizing and endotoxin testing on every lot.
Stem Cell Products
Umbilical cord MSCs, Wharton's jelly, amniotic membrane, adipose-derived concentrates. AATB-accredited tissue banks only, full donor traceability.
NAD+ & Longevity Compounds
NMN, NR, NAD+ precursors, Spermidine, MOTS-c, Tesamorelin. Pharmaceutical-grade sourcing from cGMP manufacturers - verified against the same API grade retail brands resell.
Growth Factors & Cytokines
IGF-1, EGF, FGF, PDGF, TGF-β, and proprietary blends. Full cytokine profile validation, endotoxin testing, and cold-chain logistics included.
Botanical & Adaptogenic APIs
Lion's Mane, Ashwagandha KSM-66, Bacopa, Rhodiola, and other pharmaceutical-grade adaptogen actives, third-party tested.
Biologic Devices & Delivery Systems
Microneedle patches, liposomal encapsulation systems, IV bag systems, and reconstitution kits - medical-device-grade consumables sourced alongside your biologics.
Custom Formulation & White-Label
Concept-to-finished-product: custom synthesis, proprietary blends, private-label manufacturing. Every supplier negotiation includes MOQ, exclusivity, and quality-guarantee clauses.
BioChain is a professional-grade practice built for established accounts. We require a minimum of $50,000 in annual biologics spend to engage - below that threshold, the savings math doesn't clear our fee structure. At $50K and above, it compounds dramatically.
Verified Market Intelligence, By Category
Based on BioChain SPY Index closed transaction data from the last 90 days. Quality-adjusted only - if the cheaper option has inferior documentation, it is not the benchmark. Exact figures are shared once we understand your fit - we're a sourcing partner, not a price list.
| Product | Street Price | Typical Saving | What Else You Get |
|---|---|---|---|
| BPC-157 · 5mg vial | $35–$75/vial | 38–65%+ | HPLC purity report, lot traceability, cold-chain SLA |
| TB-500 · 5mg vial | $40–$80/vial | 45–68%+ | Mass spec, sequence confirmation, research-use docs |
| Semaglutide analog · 10mg research | $280–$650/unit | 45–70%+ | Synthesis pathway confirmation, import compliance docs |
| MSC Exosomes · 1B particles | $1,200–$3,500/vial | 30–55%+ | NTA particle sizing, endotoxin test, donor consent docs |
| Umbilical Cord MSCs · 5M cells | $2,000–$8,000/unit | 25–50%+ | Viability guarantee, cryopreservation SLA, full donor chain |
| NMN pharmaceutical grade · 1kg | $800–$2,500/kg | 40–60%+ | HPLC purity ≥99%, heavy metals testing |
| NAD+ IV Drip Kit · clinic-grade | $180–$380/kit | 45–63%+ | Medical-device-grade consumables, unified supply chain |
| Full BioChain Advisory · ongoing | Standard retainer | 300%+ ROI | SPY Index access, supplier negotiation, contract architecture |
Savings percentages reflect BioChain SPY Index closed transaction data. Street prices verified from current retail and direct-channel sources as of Q2 2026. The + on every saving reflects that RampRate's supplier partnerships frequently produce pricing below published wholesale depending on account fit, volume commitment, and supplier strategic alignment. All accounts require a minimum of $50,000 in annual biologics spend. RampRate does not publish target prices - the sourcing audit produces your actual benchmark.
Why Some of Our Clients Pay Less Than Wholesale
Most procurement advisors negotiate against the street price. RampRate negotiates against the supplier's cost structure. After 24 years of directing volume at the manufacturers and labs that supply the supply chain, we have relationships that exist below the distributor tier entirely. When the fit is right - meaning your account volume, specification consistency, and payment terms align with what a supplier needs to grow - we can structure agreements that put you at or below the price a regional distributor pays. The fit determines the outcome. The sourcing audit determines the fit.
Request Your Sourcing AuditThe Accounts That Get Maximum Value From BioChain
Not every buyer is the right fit. We do our best work with organizations that have meaningful scale, documented quality requirements, and a commitment to verified sourcing over lowest-price guessing.
Ideal Client Characteristics
Pacific Longevity Partners
Multi-location longevity clinic group - 3 locations, Southern California
Purchasing through two distributors and one direct manufacturer. No unified COA standard. Exosome particle counts unverified. NMN sourced at retail pricing with no volume commitment.
41% average reduction across benchmarked categories. Supplier consolidation from 3 to 1 primary. First-time exclusivity window on top peptide SKU. Elimination of 2 documentation gaps carrying regulatory exposure.
Not All Suppliers Are Equal. Supplier Strength Is Everything.
At BioChain, we do not simply find you a cheaper supplier. We evaluate every supplier against a 12-variable qualification matrix and score them on Supplier Strength - a composite measure of how much leverage, reliability, and documentation they can deliver to your account. The stronger the supplier's profile relative to your account size and specification, the better your outcome. And the better the fit between your account and the supplier's growth objectives, the more likely you are to land below-wholesale terms.
| Variable | Weight |
|---|---|
| GMP Certification Status | 15% |
| COA Completeness (HPLC, mass spec, endotoxin, heavy metals, microbial) | 15% |
| Third-Party Testing Independence | 12% |
| Cold-Chain Infrastructure | 10% |
| Lot Traceability | 10% |
| Volume Capacity at Your Scale | 10% |
| Reorder Reliability (12-month on-time rate) | 8% |
| Regulatory History (warning letters, recall history) | 8% |
| Contract Flexibility (MOQ, exclusivity, quality guarantee) | 7% |
Pacific Biologics Supply Co. (illustrative)
MSC-Derived Exosomes - IV-Grade
FDA-registered facility · cGTP compliant · Dual-lab COA verified · NTA particle-count verified
Zero warning letters · Zero recalls · 4-year operating history
Open to exclusivity windows for accounts above $200K annually · Quality guarantee clause available · Lot reservation rights negotiable at 90-day commit
This supplier is in active growth mode and needs anchor accounts in new geographies. An account committing $150K+ annually with 90-day purchase orders qualifies for distributor-tier pricing. Fit determines access to that tier.
Supply Chain Intelligence Built for Biology
Supplier Qualification Matrix
12-variable scoring: GMP status, COA completeness, HPLC purity standards, endotoxin testing, NTA particle sizing, cold-chain infrastructure, and real buyer feedback. No supplier enters the network on reputation alone.
BioChain SPY Index
Live market pricing across our vetted manufacturer network - per milligram, per vial, per million particles. What comparable buyers actually paid, updated from closed transactions.
Provenance & Chain-of-Custody
Every order ships with verified documentation: donor tissue consent records, lot traceability, third-party lab reports, and customs compliance paperwork.
Negotiation & Contract Architecture
Volume pricing, exclusivity windows, quality-guarantee clauses, and reorder SLAs negotiated on your behalf - structured to protect you as you scale.
The Thinking Behind the Supply Chain
The Questions Clinic Directors Ask First
Regenerative Capital Meets Regenerative Medicine
BioChain Sourcing is the supply chain infrastructure for what ImpactSoul builds on the capital side. Verified, ethically sourced supply chains are the trust layer that connects regenerative medicine providers to impact-aligned capital.
Explore ImpactSoulWhat Clinics and Practices Say
“RampRate's sourcing methodology gave us confidence we had never had with our peptide suppliers. They found us a cGMP manufacturer with better documentation - and we stopped guessing about what was in the vial.”
“We had no idea our exosome supplier's particle counts were off. RampRate's supplier audit caught it before we used the product clinically.”
“The same rigor they brought to our data center negotiation, they brought to our biologics supply chain. Different industry. Same intelligence engine.”
300%+ ROI or You Don't Pay
The sourcing audit is always free. If we don't deliver 300%+ ROI on our BioChain sourcing engagements, you don't pay.
Start a Sourcing Conversation